503B Compliance
USP <797> for sterile compounding, built into the software
USP <797> sets the bar for compounding sterile preparations: controlled environments, monitored air quality, verified personnel, and beyond-use dates that reflect real conditions. For a 503B outsourcing facility, that means thousands of data points across rooms, batches, and shifts — and paper simply cannot keep up. Clarix was engineered so USP <797> alignment is the default workflow, not a retrofit.
Where paper breaks down under USP <797>
Manual log sheets are error-prone and slow. Environmental excursion tracing can take days of auditing paper records. Beyond-use dates are calculated by hand from lookup sheets — a recipe for transcription deviations in exactly the areas inspectors scrutinize. Clarix replaces each of those failure modes with an automated, audit-ready path.
How Clarix supports USP <797> in daily operations
Dynamic beyond-use date calculations
Clarix computes BUDs with USP <797> rules per batch — no fixed-value templates, no manual lookup sheets. The calculation reflects the actual preparation conditions and is captured in the electronic batch record.
Environmental monitoring with instant excursion tracing
The environmental monitoring module tracks room conditions and immediately auto-links any excursion to affected batches — replacing days of manual log-sheet auditing with a query that runs in seconds.
Glove-friendly execution in the cleanroom
Technicians run batches on a glove-friendly iPad client. Barcode scan matching verifies constituent lots against the master formula — no keyboard lot typing, no transcription risk, fewer touchpoints in the cleanroom.
Personnel, media fills, and documentation
Training records, media fill workflows, and audit-ready documentation stay in one system — so garbing, qualification, and competency evidence is available when inspectors ask.
USP <797> and 21 CFR Part 11, together
Compounding facilities sit at the intersection of USP standards and FDA regulations. Clarix pairs USP <797> workflows with 21 CFR Part 11 controls — dual e-signatures, immutable audit trails, and a turnkey validation package — so one platform covers both.
See the full engineering detail in our USP <797>& cGMP documentation. Ready to see it in action? Request a pilot.
Frequently asked questions
What is USP <797>?
USP <797> is the United States Pharmacopeia chapter that establishes standards for compounding sterile preparations (CSPs). It covers cleanroom design, environmental monitoring, personnel garbing and training, beyond-use dates (BUDs), and documentation to prevent contamination and patient harm.
How does Clarix calculate beyond-use dates?
Clarix computes BUDs dynamically using USP <797> rules based on each batch's actual conditions — instead of fixed-value database templates or manual lookup sheets. Expiration reflects the real compounding context of the preparation.
Does Clarix support environmental monitoring?
Yes. Clarix includes an environmental monitoring module and auto-links batch-to-room excursions, so a cleanroom excursion is immediately traceable to affected batches instead of requiring days of manual log-sheet auditing.
Is Clarix designed for cleanroom use?
Yes. Compounding technicians execute sterile operations on a glove-friendly iPad client with barcode scan matching — eliminating keyboard-based lot typing in the cleanroom.